Evidence map›Paper›PMID 19542618›Full record

ArticleJournal of Alzheimer's disease : JAD2009

Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins.

Enika Nagababu, Peter V Usatyuk, Divya Enika, Viswanathan Natarajan, Joseph M Rifkind

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Low-frequency Raman spectra of amyloid fibrils.The Journal of chemical physics · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Enika NagababuMolecular Dynamics Section, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
Peter V Usatyuk
Divya Enika
Viswanathan Natarajan
Joseph M Rifkind
University of Chicago · USNational Institute on Aging · USNational Institutes of Health · US

Funding

Structure-function Relationships In Hemoglobin And ErythrocytesZIAAG000047 · NIA · NATIONAL INSTITUTE ON AGING · PI RIFKIND, JOSEPH · 2009 to 2013
$2.1M
STRUCTURE-FUNCTION RELATIONSHIPS IN HEMOGLOBIN AND ERYTHROCYTESZ01AG000047 · NIA · NATIONAL INSTITUTE ON AGING · PI RIFKIND, JOSEPH M · 1985 to 2008
$1.3M
Intramural NIH HHS Z01 AG000047
6 · The paper itself

Abstract

Neuronal inflammation is very common in Alzheimer's disease (AD). This inflammation can be caused by infiltration of neutrophils across the blood brain barrier. Endothelial permeability changes are required for the infiltration of high molecular weight components to the brain. Deposition of toxic amyloid-beta (A beta) fibrils in the cerebral vasculature, as well as in brain neurons, has been implicated in the development of AD. This study investigates the effect of A beta fibrils on the permeability of the endothelium and the mechanism for the observed permeability changes. A beta(1-40) and A beta(1-42) fibrils, but not monomers, were found to increase permeability of bovine pulmonary arterial endothelial cells in a dose- and time dependent manner as detected by transendothelial electrical resistance. This increase in permeability is only partially (25%) inhibited by catalase and is not associated with an increase in cytosolic Ca+2 or tyrosine phosphorylation. These results indicate that hydrogen peroxide is not the primary mediator for the permeability changes. Treatment of cells with both amyloid fibrils resulted in stress fiber formation, disruption and aggregation of actin filaments, and cellular gap formation. The results of this study reveal that A beta increases the permeability of endothelium by inducing change in the cytoskeleton network.

Indexed as

Amyloid beta-PeptidesAnimalsBlotting, WesternCalciumCattleCell Membrane PermeabilityCells, CulturedCytoskeletal ProteinsElectric ImpedanceEndothelial CellsEndothelium, VascularMicroscopy, FluorescenceOrganophosphatesPolymersPulmonary ArteryTime FactorsAmyloid beta-PeptidesCalciumCytoskeletal ProteinsOrganophosphatesPolymerstyrosine polyphosphate

Identifiers

PMID19542618
PMCPMC2852470
OpenAlexW1605499081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.